| Title : Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial - Maki-Petaja_2021_Hypertension__HYPERTENSIONAHA12016454 |
| Author(s) : Maki-Petaja KM , McGeoch A , Yang LL , Hubsch A , McEniery CM , Meyer PAR , Mir F , Gajendragadkar P , Ramenatte N , Anandappa G , Santos Franco S , Bond SJ , Schonlieb CB , Boink Y , Brune C , Wilkinson IB , Jodrell DI , Cheriyan J |
| Ref : Hypertension , :HYPERTENSIONAHA12016454 , 2021 |
| Abstract : Maki-Petaja_2021_Hypertension__HYPERTENSIONAHA12016454 |
| ESTHER : Maki-Petaja_2021_Hypertension__HYPERTENSIONAHA12016454 |
| PubMedSearch : Maki-Petaja_2021_Hypertension__HYPERTENSIONAHA12016454 |
| PubMedID: 33775123 |
Maki-Petaja KM, McGeoch A, Yang LL, Hubsch A, McEniery CM, Meyer PAR, Mir F, Gajendragadkar P, Ramenatte N, Anandappa G, Santos Franco S, Bond SJ, Schonlieb CB, Boink Y, Brune C, Wilkinson IB, Jodrell DI, Cheriyan J (2021)
Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial
Hypertension
:HYPERTENSIONAHA12016454
Maki-Petaja KM, McGeoch A, Yang LL, Hubsch A, McEniery CM, Meyer PAR, Mir F, Gajendragadkar P, Ramenatte N, Anandappa G, Santos Franco S, Bond SJ, Schonlieb CB, Boink Y, Brune C, Wilkinson IB, Jodrell DI, Cheriyan J (2021)
Hypertension
:HYPERTENSIONAHA12016454